PDL BioPharma, Inc.: key financial figures for fiscal year 2020 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Cash Flows from Operating Activities (FY2020)

$7.5M

Source: PDL BioPharma, Inc. 10-K filing (FY2020). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.